https://www.selleckchem.com/pe....ptide/octreotide-ace
iovascular deaths as a competing risk, there was not a significant change in the risk estimation for cardiovascular death. Registration URL https//www.clinicaltrials.gov; Unique identifier NCT01732822. Among patients with symptomatic peripheral artery disease, noncardiovascular causes of death reflected a high proportion (40%) of deaths. Accounting for noncardiovascular deaths as a competing risk, there was not a significant change in the risk estimation for cardiovascular death. Registration URL https//www.clinicaltrials.gov;
Like
Comment
Share
